Get informed when a big investor buys or sells
+ FollowUndervalued by 16.3% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $4.54 Billion |
|---|---|
| Enterprise Value | $5.63 Billion |
| Annual dividend | $1.59 |
| Dividend yield | 2.74% |
| Earnings per Share | $3.63 |
| Beta | 0.29 |
| Outstanding Shares | 49,889,473 |
| P/E Ratio | 28.59 |
|---|---|
| PEG | -115.13 |
| Price to Sales | 0.6 |
| Price to Book Ratio | 3.55 |
| Enterprise Value to Revenue | 0.68 |
| Enterprise Value to EBIT | 13.01 |
| Enterprise Value to Net Income | 16 |
| Total Debt to Enterprise | 0.2 |
| Debt to Equity | 0.8 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Galenica AG operates as a prominent healthcare services provider, delivering solutions across Switzerland and internationally. Its operations are structured into two core divisions: Products & Care, and Logistics & Information Technology...